Kolexia
Jacquot Stephane Oncologie radiothérapie
Jacquot Stephane
Oncologie radiothérapie
Polycl Pasteur Pezenas
Pézenas, France
60 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Tumeurs du sein Tumeurs du côlon Tumeurs du rectum Tumeurs du foie Métastase tumorale Fatigue Adénocarcinome Hypertrophie

Collaborateurs

Voir plus
Toledano Ivan
Toledano Ivan
Selarl Onco 34, Saint-Jean-de-Védas, France
Villanueva Cristian
Villanueva Cristian
Oncoclem, Saint-Jean-de-Védas, France
Lauche Olivier
Lauche Olivier
Oncoclem, Saint-Jean-de-Védas, France
Francois Eric
Francois Eric
Centre Antoine Lacassagne, Nice, France

Industries

Voir plus
MSD
13 collaboration(s)
Dernière en 2023
Novartis
4 collaboration(s)
Dernière en 2023
AstraZeneca
3 collaboration(s)
Dernière en 2023
VIATRIS MEDICAL
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.
JAMA network open   05 septembre 2023
Breast Cancer: How Hippotherapy Bridges the Gap between Healing and Recovery-A Randomized Controlled Clinical Trial.
Cancers   19 février 2023
Predictive value of vascular endothelial growth factor polymorphisms for maintenance bevacizumab efficacy in metastatic colorectal cancer: an ancillary study of the PRODIGE 9 phase III trial.
Therapeutic advances in medical oncology   26 décembre 2022
HippoBreastCa: Effect of Multidisciplinary Management by Hippotherapy on the Quality of Life of Women With a Diagnosis of Breast Cancer: Randomized Controlled Clinical Trial on the Effectiveness of the Therapeutic Intervention
Essai Clinique (Alliance Equiphoria)   30 septembre 2022
TIME: Randomized Phase II Study of First-line FOLFIRI Plus Cetuximab for 8 Cycles Followed by Either Single-agent Cetuximab as Maintenance Therapy or Observation in Patients With Wild-type KRAS and NRAS Metastatic Colorectal Cancer
Essai Clinique (Unicancer)   23 mars 2022
Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   24 septembre 2021
Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer: Multicenter Phase III Randomized Study of FOLFIRI Plus Bevacizumab Following or Not by a Maintenance Therapy With Bevacizumab in Patients With Non-Pretreated Metastatic Colorectal Cancer
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   27 mars 2020
Les matinales du 5 mars 2020 avec Nicolas Entz et Louis Daufresne.
Youtube @ Radio Notre Dame   01 mars 2020
Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab.
Gut   17 mai 2019
Prodige20: Evaluation of Bevacizumab in Combination With First-Line Chemotherapy in Patients Aged 75 Years of Older With Metastatic Colorectal Adenocarcinoma
Essai Clinique (CHU Dijon-Bourgogne)   26 décembre 2018